glp-1 tired If you’re on a and feel more than expected, your symptoms are real — and they deserve evaluation.⁣⁣, ⁣⁣, Fatigue during weight loss is often multifactorial and frequently related to Do GLP-1 Shots Make You

Tirzepatide is a GIP and GLP-1 receptor antagonist that should be approved for weight loss this year by the FDA

[99] showed different results using a retrospective matched cohort study that utilized the TriNetX, found no increased risk of NAION or ischemic optic neuropathy among patients with T2DM or elevated BMI prescribed semaglutide over 5 years

How It Compares With Approved Incretin Options Retatrutide is often compared with semaglutide and tirzepatide because all are incretin-related medicines

More recently, tirzepatide, which targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, has received approval for treating type 2 diabetes and/or obesity

Whether retatrutide offers advantages over currently approved agents for outcomes such as insulin resistance, dyslipidaemia, or cardiovascular risk is being studied in ongoing trials